logo

For the Inventor, By the Inventor

San Gregorio di Catania, Italy

Clelia Carmen Galati

This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignee: Stmicroelectronics S.r.l.. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clelia Carmen Galati. Retrieved from https://idiyas.com/inventor/clelia-carmen-galati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 62.5

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 58(Granted Patents)


Company Filing History:

goldMedal8 out of 5,691 
 
Stmicroelectronics S.r.l.
 patents

Years Active: 2015-2023

Loading Chart...
8 patents (USPTO):Explore Patents
1. 11761034 - Integrated device for real time quantitative PCR (2023-09-19),
2. 10941440 - Integrated device for real time quantitative PCR (2021-03-09),
3. 10871462 - MOx-based gas sensor and manufacturing method thereof (2020-12-22),
4. 10144959 - Integrated device for real time quantitative PCR (2018-12-04),
5. 9658158 - Diagnostic device with integrated photodetector, and diagnostic system including the same (2017-05-23),
6. 9103787 - Optically accessible microfluidic diagnostic device (2015-08-11),
7. 9062343 - Integrated device for real time quantitative PCR (2015-06-23),
8. 8975607 - Confocal optical detector, detector array, and manufacturing method thereof (2015-03-10),

Title: Clelia Carmen Galati: Innovator in Real-Time Quantitative PCR Technology

Introduction

Clelia Carmen Galati is a distinguished inventor based in San Gregorio di Catania, Italy. He has made significant contributions to the field of molecular biology, particularly in the development of innovative technologies for real-time quantitative PCR. With a total of 8 patents to his name, Galati's work has advanced the capabilities of nucleic acid detection.

Latest Patents

Among his latest patents is an integrated device for real-time quantitative PCR. This method allows for the real-time quantitative detection of single-type target nucleic acid sequences amplified using PCR in a microwell. The process involves introducing a sample containing target nucleic acid sequences, magnetic primers, and labeling probes into the microwell. An amplification cycle is performed to create labeled amplicons. The magnetic primers are then attracted to a surface through a magnetic field, forming a layer that includes labeled amplification products and free magnetic primers. Finally, the labeled amplification products are detected in the layer using a surface-specific reading method.

Career Highlights

Clelia Carmen Galati is currently employed at STMicroelectronics S.r.l., where he continues to innovate and develop cutting-edge technologies. His work has not only contributed to the scientific community but has also enhanced the capabilities of diagnostic tools used in various applications.

Collaborations

Throughout his career, Galati has collaborated with notable colleagues, including Lucio Renna and Natalia Maria Rita Spinella. These collaborations have fostered a productive environment for innovation and have led to the successful development of several patents.

Conclusion

Clelia Carmen Galati's contributions to the field of real-time quantitative PCR technology exemplify his dedication to innovation and scientific advancement. His patents reflect a commitment to improving molecular detection methods, making a lasting impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…